Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Pharmaceutical Industry Lobbyists

Worked with pharmaceutical industry lobbyists on passage of 1988 process patent amendments, assisting in meetings with congressional staff and drafting report language regarding what constitutes a "material change" for purposes of determining liability when products are modified prior to importation.